Clin2
NCT06285500Worth exploringRecruiting

Single patient cancer treatment study

Advanced CancerRare Diseases

Part of Cancer clinical trials.

This study creates a unique treatment plan based on the genetic changes found in your tumor. A team of experts will review your cancer's molecular profile to decide the best next therapy for you, even if standard options are not clear.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
400 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have had genomic testing done on your tumor to look for genetic changes.
  • Your doctor and a hospital expert team review your results to decide on a personalized treatment.
  • You are willing to try a treatment that is made specifically for your cancer's genetic makeup.
  • There may not be standard treatment options available for your type of cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02906943Recruiting
Testing cancer tissue to guide targeted treatment choices

This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.

Hamilton, Ontario
NCT07346209Not yet recruiting· Phase 2
Personalized cancer treatment study

This study tests whether choosing cancer treatments based on the unique genetic changes in your tumor can help people with advanced cancer live longer. You would receive FDA-approved drugs that match your tumor's specific markers.

La Jolla, California
NCT06855134Recruiting
Genome-guided treatment for advanced rare cancers

This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.

Augsburg
NCT05852522Recruiting
Testing treatment planning to help eradicate rare advanced cancers

This trial looks at a more tailored way to choose treatment for people with rare cancers that have spread or grown locally and can’t be cured with standard therapies. The goal is to better target the tumor to improve the chance of tumor shrinkage or eradication.

Heidelberg
NCT02290522Recruiting
Personalized cancer treatment study

This trial tests whether tailoring treatment to your tumor's specific genetic makeup can help when standard treatments are no longer working. It may give you access to therapies that are more likely to work for your cancer.

Copenhagen
NCT06692491Not yet recruiting· Phase 2
Precision treatment for rare tumors guided by lab tests

This trial tests a personalized approach for people with rare advanced or metastatic solid tumors. Doctors use special lab tests on your tumor tissue and blood to find the best treatment for you.

Hear when a new Advanced Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.